9:31113. Lumbar Total Disc Replacement With the ProDisc-L Artificial Disc versus Fusion: A Prospective Randomized Multi-Center Food and Drug Administration IDE Trial

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

Faculty Opinions recommendation of A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9142.466622 ◽

2006 ◽

Author(s):

Constantin Schizas

Keyword(s):

Clinical Outcomes ◽

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITÉ artificial disc versus lumbar fusion: Five-year follow-up

The Spine Journal ◽

10.1016/j.spinee.2008.08.007 ◽

2009 ◽

Vol 9 (5) ◽

pp. 374-386 ◽

Cited By ~ 196

Author(s):

Richard D. Guyer ◽

Paul C. McAfee ◽

Robert J. Banco ◽

Fabian D. Bitan ◽

Andrew Cappuccino ◽

...

Keyword(s):

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemptions Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artificial Disc Versus Lumbar Fusion: Part 1: Evaluation of Clinical Outcomes

Yearbook of Orthopedics ◽

10.1016/s0276-1092(08)70535-2 ◽

2006 ◽

Vol 2006 ◽

pp. 258-259

Author(s):

M.J. Yaszemski

Keyword(s):

Clinical Outcomes ◽

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of Lumbar Total Disc Replacement With the CHARITÉ ™ Artificial Disc Versus Lumbar Fusion

Spine ◽

10.1097/01.brs.0000170561.25636.1c ◽

2005 ◽

Vol 30 (14) ◽

pp. 1576-1583 ◽

Cited By ~ 216

Author(s):

Paul C. McAfee ◽

Bryan Cunningham ◽

Gwen Holsapple ◽

Karen Adams ◽

Scott Blumenthal ◽

...

Keyword(s):

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemptions Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artificial Disc Versus Lumbar Fusion

Spine ◽

10.1097/01.brs.0000170587.32676.0e ◽

2005 ◽

Vol 30 (14) ◽

pp. 1565-1575 ◽

Cited By ~ 387

Author(s):

Scott Blumenthal ◽

Paul C. McAfee ◽

Richard D. Guyer ◽

Stephen H. Hochschuler ◽

Fred H. Geisler ◽

...

Keyword(s):

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artifiical Disc Versus Lumbar Fusion: Part II: Evaluation of Radiographic Outcomes and Correlation of Surgical Technique Accuracy With Clinical Outcomes

Yearbook of Orthopedics ◽

10.1016/s0276-1092(08)70536-4 ◽

2006 ◽

Vol 2006 ◽

pp. 260-261 ◽

Cited By ~ 1

Author(s):

M.J. Yaszemski

Keyword(s):

Surgical Technique ◽

Clinical Outcomes ◽

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Radiographic Outcomes ◽

The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment

SAS Journal ◽

10.1016/s1935-9810(07)70041-5 ◽

2007 ◽

Vol 1 (1) ◽

pp. 8-11 ◽

Cited By ~ 2

Author(s):

Scott L. Blumenthal ◽

Richard D. Guyer ◽

Fred H. Geisler ◽

Paul C. McAfee ◽

John J. Regan

Keyword(s):

United States ◽

Adverse Events ◽

Drug Administration ◽

Total Disc Replacement ◽

The United States ◽

Disc Replacement ◽

54 Total disc replacement (TDR)lumbarFood and Drug Administration-Investigational Device Exemption (FDA-IDE) trialsTotal disc replacement (TDR)lumbarcomplications ofLumbar spinetotal disc replacement (TDR)Food and Drug Administration-Investigational Device Exemption (FDA-IDE) trialsLumbar spinetotal disc replacement (TDR)complications ofComplicationsof lumbar total disc replacement (TDR)Arthroplasty, disclumbarFood and Drug Administration-Investigational Device Exemption (FDA-IDE) trialsArthroplasty, disclumbarcomplications ofComplications of Investigational Device Exemption Trial after Total Disc Replacement

Dynamic Reconstruction of the Spine ◽

10.1055/b-0035-108566 ◽

2015 ◽

Cited By ~ 1

Keyword(s):

Drug Administration ◽

Total Disc Replacement ◽

Disc Replacement ◽

The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment

The International Journal of Spine Surgery ◽

10.1016/sasj-2006-0001-rr ◽

2007 ◽

Vol 1 (1) ◽

pp. 8-11

Author(s):

Scott L. Blumenthal ◽

Richard D. Guyer ◽

Fred H. Geisler ◽

Paul C. McAfee ◽

John J. Regan

Keyword(s):

United States ◽

Adverse Events ◽

Drug Administration ◽

Total Disc Replacement ◽

The United States ◽

Disc Replacement ◽

Faculty Opinions recommendation of Evaluation of surgical volume and the early experience with lumbar total disc replacement as part of the investigational device exemption study of the Charité Artificial Disc.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1040755.489790 ◽

2006 ◽

Author(s):

Constantin Schizas

Keyword(s):

Total Disc Replacement ◽

Early Experience ◽

Disc Replacement ◽

Surgical Volume ◽

Artificial Disc ◽